The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: Pharmacological correlation with the D 2-like type

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 6, 2011, Pages 506-512

  Manrique Maldonado, Guadalupe ^a   González Hernández, Abimael ^a   Marichal Cancino, Bruno A ^a   Villamil Hernández, Ma Trinidad ^a   del Mercado, Oscar Alcántara Vázquez ^a   Centurión, David ^a   Villalón, Carlos M ^a  

^a Cinvestav Coapa   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DESIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR; GALLAMINE; NORADRENALIN; QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART RATE; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; DECEREBRATE STATE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; HEART RATE; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SYMPATHETIC NERVOUS SYSTEM; VASOMOTOR SYSTEM;

RATTUS;

EID: 81255157873     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00762.x     Document Type: Article

References (28)

1. Willems JL, Buylaert WA, Lefebvre RA, Bogaert MG. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 1985;37:165-216.
2. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998;80:149-82.
3. Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol 2003;95:19-27.
4. Missale C, Nash S, Robinson S, Jaber M, Caron M. Dopamine receptors: from structure to function. Physiol Rev 1998;78:189-225.
5. Seeman P, Van Tol MH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994;15:264-70.
6. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011;63:182-217.
7. Goldberg LI. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972;24:1-24.
8. Goldberg LI, Volkman PH, Kohli JD. A comparison of the vascular dopamine receptors with other dopamine receptors. Annu Rev Pharmacol Toxicol 1978;18:57-79.
9. Villalón CM, Ramírez-San Juan E, Sánchez-López A, Bravo G, Willems EW, Saxena PR et al. Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation. Pharmacol Toxicol 2003;92:165-72.
10. Hietala J, MacDonald E, Scheinin M. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors. Acta Pharmacol Toxicol 1986;59:291-7.
11. 1 receptor antagonists. J Auton Pharmacol 2000;20:313-23.
12. Shipley RE, Tilden JH. A pithed rat preparation suitable for assaying pressor substances. Proc Soc Exp Biol Med 1947;64:453-5.
13. Kleiman LI, Radford EP. Ventilation standards for small mammals. J Appl Physiol 1964;19:360-2.
14. Gillespie JS, Maclaren A, Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol 1970;40:257-67.
15. 1D subtypes. Br J Pharmacol 1998;124:1001-11.
16. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1980;32:337-55.
17. Villalón CM, Contreras J, Ramírez-San Juan E, Castillo C, Perusquía M, López-Muñoz FJ et al. 5-hydroxytryptamine inhibits pressor responses to preganglionic sympathetic nerve stimulation in pithed rats. Life Sci 1995;57:803-12.
18. Villalón CM, Contreras J, Ramírez-San Juan E, Castillo C, Perusquía M, Terrón JA. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat. Br J Pharmacol 1995;116:3330-6.
19. Steel RGD, Torrie JH. Principles and Procedures of Statistics, a Biomedical Approach, 2nd edn. Tokyo, McGraw-Hill, Kogakusha Ltd, 1980.
20. Flavahan NA, Grant TL, McGrath JC. Analysis of the α-adrenoceptor-mediated, and other, components in the sympathetic vasopressor responses of the pithed rat. Br J Pharmacol 1985;86:265-74.
21. Grant TL, McGrath JC. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat. Br J Pharmacol 1988;95:1220-8.
22. Leysen JE. Serotonergic binding sites. In: Vanhoutte PM (ed.). Serotonin and the Cardiovascular System. Raven Press, New York, 1985;43-62.
23. Bechtel WD, Mierau J, Pelzer H. Biochemical pharmacology of pirenzepine. Similarities with tricyclic antidepressants in antimuscarinic effects only. Arzneimittelforschung 1986;36:793-6.
24. Roquebert J, Moran A, Demichel P. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat. J Auton Pharmacol 1992;12:291-8.
25. Rand MJ, Majewski H, Wong-Dusting H, Story DF, Loiacono RE, Ziogas J. Modulation of neuroeffector transmission. J Cardiovasc Pharmacol 1987;10:S33-S44.
26. Boehm S, Kubista H. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 2002;54:43-99.
27. De Jong AP, Vehage M. Presynaptic signal transduction pathways that modulate synaptic transmission. Curr Opin Neurobiol 2009;19:245-54.
28. Horn PT, Kohli JD. Studies on the location of catecholamine receptors in canine sympathetic ganglia. Eur J Pharmacol 1992;224:103-7.